---
figid: PMC3782519__onci-2-e25124-g1
figlink: /pmc/articles/PMC3782519/figure/F1/
number: F1
caption: Figure 1. Inhibitory activity of miR-124 on multiple nodes of the STAT3 signaling
  pathway. Signal transducer and activator of transcription 3 (STAT3) can be activated
  by a variety of ligands, including interleukin-6 (IL-6) and the epidermal growth
  factor (EGF). miR-124 not only can downregulate signal transducers like SHC1 and
  STAT3, but also can occasionally inhibit the phosphorylation of mitogen-activated
  protein kinases 1 and 3 (MAPK1 and MAPK3), probably in a contextual fashion, when
  IL-6 is absent and cells are highly dependent on EGF receptor (EGFR) signaling.
pmcid: PMC3782519
papertitle: MicroRNAs as novel immunotherapeutics.
reftext: Amy B Heimberger, et al. Oncoimmunology. 2013 Aug 1;2(8):e25124.
pmc_ranked_result_index: '86685'
pathway_score: 0.9543835
filename: onci-2-e25124-g1.jpg
figtitle: MicroRNAs as novel immunotherapeutics
year: '2013'
organisms:
- Homo sapiens
ndex: 438db627-deec-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3782519__onci-2-e25124-g1.html
  '@type': Dataset
  description: Figure 1. Inhibitory activity of miR-124 on multiple nodes of the STAT3
    signaling pathway. Signal transducer and activator of transcription 3 (STAT3)
    can be activated by a variety of ligands, including interleukin-6 (IL-6) and the
    epidermal growth factor (EGF). miR-124 not only can downregulate signal transducers
    like SHC1 and STAT3, but also can occasionally inhibit the phosphorylation of
    mitogen-activated protein kinases 1 and 3 (MAPK1 and MAPK3), probably in a contextual
    fashion, when IL-6 is absent and cells are highly dependent on EGF receptor (EGFR)
    signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - PIAS3
  - MAPK1
  - MAPK3
  - MAP2K1
  - MAP2K2
  - EGF
  - JAK2
  - NRAS
  - HRAS
  - TYK2
  - EGFR
  - JAK1
  - JAK3
  - SHC1
  - IL6R
  - STAT3
  - IL6
  - Cancer
genes:
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PIAS3
  symbol: PIAS3
  source: hgnc_symbol
  hgnc_symbol: PIAS3
  entrez: '10401'
- word: MAPK1/3
  symbol: MAPK1
  source: hgnc_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK1/3
  symbol: MAPK3
  source: hgnc_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: Jak/Tyk2
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Jak/Tyk2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Jak/Tyk2
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: Jak/Tyk2
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: SHC1
  symbol: SHC1
  source: hgnc_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: Jak/Tyk2
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IL-6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3782519__F1
redirect_from: /figures/PMC3782519__F1
figtype: Figure
---
